Safety of second dose of mRNA COVID-19 vaccines after first-dose allergic reactions
(JAMA Network) What The Study Did: Researchers examined the safety of the second dose of the Pfizer-BioNTech or Moderna COVID-19 vaccines in patients who experienced an allergic reaction to the first dose.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news
More News: Allergy & Immunology | COVID-19 | Infectious Diseases | Pfizer | Study | Vaccines